Phase I trial of radiolabeled antibody as an adjuvant to radiation therapy for unresectable non-small cell bronchogenic carcinoma: A Radiation Therapy Oncology Group study

D. J. Moylan, S. E. Order, E. Zinreich

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Phase I trial of radiolabeled antibody as an adjuvant to radiation therapy for unresectable non-small cell bronchogenic carcinoma: A Radiation Therapy Oncology Group study'. Together they form a unique fingerprint.

Medicine & Life Sciences